Macrophage Activation Syndrome

Macrophage Activation Syndrome is a rare disorder in children and arises from abnormal activation and proliferation of T-cells and activation of macrophages. Discover the latest research on Macrophage Activation Syndrome here.

August 25, 2020
Comment / Editorial
Open Access

COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach

Progress in Pediatric Cardiology
Teresa R HennonMark D Hicar
September 15, 2020
Case Report

A 5-year-old boy with Kawasaki disease shock syndrome, myocarditis and macrophage activation syndrome

Journal of Paediatrics and Child Health
Rakesh Kumar PilaniaSurjit Singh
August 29, 2020
Open Access

Thrombosis in COVID-19

American Journal of Hematology
Thomas C HanffJulio A Chirinos
October 6, 2020
Open Access

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

The Lancet Rheumatology
Brandon J WebbSamuel M Brown
October 3, 2020
Open Access

Highways to hell: mechanism based management of Cytokine Storm Syndromes

The Journal of Allergy and Clinical Immunology
Scott W Canna, Randy Q Cron
September 15, 2020

The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic

Acta Bio-medica : Atenei Parmensis
Francesca LamiLorenzo Iughetti
October 18, 2020
Open Access

Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares

Pediatric Rheumatology Online Journal
Alice S ChauEric J Allenspach
September 17, 2020
Case Report

Staring at an abscess, but lupus stares back…

The Journal of the Royal College of Physicians of Edinburgh
Sandeep SurendranSekhar V Easwar
October 7, 2020

COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?

Current Rheumatology Reviews
Maria Celeste Fatone
September 25, 2020
Open Access

E-cigarette or Vaping-Associated Acute Lung Injury and Hemophagocytic Lymphohistiocytosis

Kim R DerespinaShivanand S Medar
September 26, 2020
Open Access

Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients

Experimental Biology and Medicine
Nausheen N HakimJohnson M Liu
September 15, 2020

Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients

The Journal of Clinical Investigation
Kazusa IshiiTerry J Fry
September 24, 2020
Open Access

Severe COVID-19: what have we learned with the immunopathogenesis?

Advances in Rheumatology
Bruno BordalloMarcelo Pinheiro
October 11, 2020
Case Report
Open Access

Severe Coronavirus Disease 2019 Infection in an Adolescent Patient After Hematopoietic Stem Cell Transplantation

Grace FislerMatthew D Taylor
October 2, 2020
Open Access

Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19

Hasan SatışAbdurrahman Tufan
October 7, 2020
Open Access

Covid-19 and kidney injury: Pathophysiology and molecular mechanisms

Reviews in Medical Virology
Elham AhmadianSepideh Zununi Vahed

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is rare lymphoproliferative disorder unicentric (localized) or multicentric (systemic). Discover the latest research here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

© 2020 Meta ULC. All rights reserved